BRIG BIO
BRIG BIO produces dairy proteins for medical nutrition through precision fermentation, creating milk proteins from microorganisms rather than cows. Its first commercial product, Alpha-lac, targets muscle mass synthesis and offers consistency that conventional dairy cannot guarantee. The company is building a scalable platform for rapid strain development and customer-specific downstream processing tailored to medical nutrition manufacturers.
- Biotechnology
Funding
Founders
Founder details are not available yet.
Product
Problem
The global demand for high-quality protein is rising rapidly due to an ageing population, increasing chronic diseases, and a growing focus on health ownership. Traditional dairy farming cannot keep pace with this growth, and rising pressure on natural resources is pushing the industry toward a projected shortage of 31 million tonnes of protein by 2030.
Solution
BRIG BIO develops dairy proteins for medical nutrition through precision fermentation, producing milk proteins from microorganisms rather than cows. The company's first commercial product, Alpha-lac, is a high-quality dairy protein designed for muscle mass synthesis in medical nutrition applications. The platform is being built to rapidly scale new strains and develop customer-specific downstream processing solutions tailored to the needs of medical nutrition manufacturers. Precision fermentation enables consistency that conventional dairy cannot guarantee, while geo-independent production removes dependency on seasonal dairy supply. The company positions its approach as complementary to traditional dairy, working alongside existing industry players to secure protein supply for clinical environments with demanding processing conditions.
Target Audience
Primary customers are manufacturers of medical nutrition products who need scalable, sustainable, and consistent high-quality dairy proteins for clinical applications.
Features
- Alpha-lac: first commercial dairy protein produced via precision fermentation, targeting muscle mass synthesis
- Scalable platform for rapid strain development and customer-specific downstream processing solutions
- Precision fermentation technology ensuring consistent product quality that conventional dairy cannot guarantee
- Geo-independent production eliminating dependency on seasonal dairy supply
- Designed for clinical environments with demanding processing conditions
- Platform approach providing partners with a clear path to product development